ACR-6840 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,926 results for “ACR-6840”

Trials

View all 4094 →

Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors

100 participants · First posted Oct 31, 2024

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

350 participants · First posted Sep 21, 2022

MLX/XLX ACR Expandable Lumbar Interbody Implants

109 participants · First posted Jun 9, 2020

Drugs

View all 495 →

EHT 6840

AG-6840

ACR-150

Organizations

View all 75 →

ACRES Commercial

United States

SerenaGroup, Inc.

United States

ACO

News

View all 1262 →

Acrivon Therapeutics Reports 44% Response Rate for CHK1/2 Inhibitor ACR-368 in Endometrial Cancer Phase II Trial

Acrivon Therapeutics Launches CLIA-Certified Laboratory to Advance Precision Medicine Development

American College of Rheumatology Launches Initiatives to Reduce Racial Disparities in Lupus Clinical Trials

Page 1 of 593